This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yanik GA, Grupp SA, Pulsipher MA, Levine JE, Schultz KR, Wall DA, et al. TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children’s Oncology Group Study (ASCT0521). Biol Blood Marrow Transplant. 2015;21:67–73.
Khurshid I, Anderson LC. Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med J. 2002;78:257–62.
Cooke KR, Jannin A, Ho V. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14:23–32.
Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation. 2004;109:159–65.
Zeilhofer U, Ashworth M, Amrolia P, Rao A, Chiesa R, Veys P, et al. Pulmonary hypertension following haematopoietic stem cell transplantation for primary haemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2013;60:521–3.
Panoskaltsis-Mortari A, Griese M, Madtes DK, Belperio JA, Haddad IY, Folz RJ, et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med. 2011;183:1262–79.
Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803–15.
Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation: part I. Circulation. 2003;108:1917–23.
Yeates L, Slatter MA, Bonanomi S, Lim WIFL, Ong SY, Dalissier A, et al. Use of defibrotide to treat transplant-associated thrombotic microangiopathy—a retrospective study of the paediatric diseases and inborn errors working parties of the european society of blood and marrow transplantation. Bone Marrow Transplant. 2017;52:762–64.
Acknowledgements
We acknowledge support for this work by the MRC/ESPRC Newcastle Molecular Pathology Node.
Author contributions
TA collected the data, performed the analysis and interpretation of the data and the writing of the manuscript. JS collected the data and contributed to manuscript writing, MAS, CO’B, AC, MT, MB contributed equally to the conceptualization of the research, manuscript writing and critical review, AS performed the analysis and interpretation of the data, manuscript writing and critical review and ARG designed and conceptualized the research project, analysis and interpretation of the data, manuscript writing and critical review at every level of the research stages.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Altmann, T., Slack, J., Slatter, M. et al. Endothelial cell damage in idiopathic pneumonia syndrome. Bone Marrow Transplant 53, 515–518 (2018). https://doi.org/10.1038/s41409-017-0042-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-017-0042-z
This article is cited by
-
Incidence and predictors of idiopathic pneumonia syndrome in hematopoietic stem cell transplant patients: a nationwide registry study
International Journal of Hematology (2022)